| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 313 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 276 |
| 2 | TACROLIMUS OINTMENT 0.1% | 276 |
| 3 | MYCOPHENOLATE MOFETIL | 256 |
| 4 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 256 |
| 5 | PREDNISONE | 204 |
| 6 | CYCLOSPORINE | 101 |
| 7 | METHYLPREDNISOLONE | 100 |
| 8 | PREDNISOLONE | 87 |
| 9 | PREDNISOLONE ORAL | 87 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | COCOA BUTTER, PHENYLEPHRINE HCL | 1 | 0.0196 |
| 1 | CLOTRIMAZOLE1% CLOTRIMAZOLE | 1 | 0.0182 |
| 2 | SODIUM PHOSPHATE, DIBASIC AND SODIUM PHOSPHATE, MONOBASIC | 1 | 0.0122 |
| 3 | BRINCIDOFOVIR | 1 | 0.0072 |
| 4 | BASILIXIMAB | 74 | 0.0062 |
| 5 | EQUINE THYMOCYTE IMMUNE GLOBULIN | 6 | 0.0058 |
| 6 | COCOA BUTTER, PHENYLEPHRINE HYDROCHLORIDE | 1 | 0.0054 |
| 7 | BEVACIZUMAB-MALY | 1 | 0.0050 |
| 8 | AURANOFIN | 1 | 0.0049 |
| 9 | ETHACRYNIC ACID | 2 | 0.0036 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Selective T Cell Costimulation Blocker [EPC] | 13 | 0.0027 |
| 1 | Antimetabolite Immunosuppressant [EPC] | 47 | 0.0022 |
| 2 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 32 | 0.0014 |
| 3 | Complement 5a Receptor Antagonist [EPC] | 7 | 0.0010 |
| 4 | Anthelmintic [EPC] | 3 | 0.0010 |
| 5 | Human Immunoglobulin G [EPC] | 17 | 0.0008 |
| 6 | Calcineurin Inhibitor Immunosuppressant [EPC] | 102 | 0.0008 |
| 7 | CD52-directed Cytolytic Antibody [EPC] | 14 | 0.0007 |
| 8 | Vitamin D3 Analog [EPC] | 14 | 0.0007 |
| 9 | Oxytocic [EPC] | 2 | 0.0007 |